SFSIG
MED icon

San Francisco Sentry Investment Group’s Medifast MED Stock Holding History

San Francisco Sentry Investment Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-9
Closed -$1K – 1010
2018
Q4 		$1K Buy
+9
New +$1.54K ﹤0.01% 878

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

San Francisco Sentry Investment Group's MED Position: Q1 2019 in Review

San Francisco Sentry Investment Group sold out of Medifast (MED) in Q1 2019, closing a stake of 9 shares — an estimated $1K sold.

San Francisco Sentry Investment Group first reported a position in MED in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 246 funds tracked by Wall St. Rank hold MED as of Q1 2019.

  • San Francisco Sentry Investment Group reported no remaining Medifast position as of Q1 2019 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 9 Medifast shares in Q1 2019, an estimated $1K.
  • San Francisco Sentry Investment Group first reported a position in Medifast in Q4 2018 and held it in 1 quarter.
  • San Francisco Sentry Investment Group's Medifast position peaked at $1K in Q4 2018.
  • 246 funds tracked by Wall St. Rank held Medifast as of Q1 2019.

Based on San Francisco Sentry Investment Group's 13F filing for Q1 2019, filed 8 May 2019.